AI-generated summary
The authors surveyed 60 people through social media about how they choose a photobiomodulation device for hair loss. Most respondents said device efficacy was the most important factor, and most preferred a hand-free device. Only eight respondents had used such a device, and just one of them was dissatisfied and stopped treatment.
- Participants
- 60
- Who or what was studied
- Adults responding to a social media-based online survey about photobiomodulation device preferences for hair loss; most had never used a photobiomodulation device.
- Limits stated in the abstract
- The survey used a small, self-selected social media sample, and only eight respondents had used a device, so the findings reflect preferences rather than measured treatment outcomes.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on tandfonline.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Androgenetic alopecia. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.